Total Funding
74
71
Total FundingPost-IPO Secondary raised
Growth Score 74 in past quarter
-17 pts
Heat Score 71 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
8489
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
- Reshma Kewalramani: President and Chief Executive OfficerPast Role: Vertex Pharmaceuticals, Executive Vice President and Chief Medical Officer
- Jeffrey Leiden: Executive ChairmanPast Role: Vertex Pharmaceuticals, President and CEO
About the Company
Vertex Pharmaceuticals is a biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases,
cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain.

